Mölnlycke Health Care AB: CEO, Zlatko Rihter, announces resignation, Guillaume Joucla appointed interim CEO

Today, it was announced that Zlatko Rihter, CEO of Mölnlycke Health Care, has informed the Board of Directors of his decision to resign. Following his decision, Guillaume Joucla, Chief Financial Officer, has been appointed interim CEO of Mölnlycke Health Care. Mölnlycke’s Board has initiated the recruitment process for a permanent CEO.

“Zlatko has been instrumental in navigating Mölnlycke through an ever‑changing world while delivering above‑market growth. The company has made significant progress, with a relentless focus on customer centricity and geographic expansion,” says Mölnlycke’s Chair of the Board, Karl-Henrik Sundström.

“It has been a privilege to lead Mölnlycke for more than five years, a period of fantastic development and growth. The company is well positioned to continue its growth journey. I am proud of what we have achieved, and I want to sincerely thank all my colleagues for their hard work and strong commitment. I would also like to thank the Board for its support during my tenure,” says Zlatko Rihter.

“We are pleased to have Guillaume Joucla serve as interim CEO and lead the company forward, building on its key strengths. Guillaume has an excellent track record and extensive experience, having served almost 20 years with the company,” says Karl-Henrik Sundström.

About Mölnlycke^®

Mölnlycke Health Care is a world-leading MedTech company that specialises in innovative solutions for wound care and surgical procedures. Mölnlycke products and solutions are used daily by hospitals, health care providers and patients in over 100 countries around the world. Founded in 1849, Mölnlycke is owned by Investor AB and headquartered in Sweden. www.molnlycke.com